LDL-containing immune complexes in the DCCT/EDIC cohort: Associations with lipoprotein subclasses

Journal of Diabetes and its Complications

Volumn 25, Issue 2, 2011, Pages 73-82

  Klein, Richard L ^a,b,c   Carter, Rickey E ^c   Jenkins, Alicia J ^a,d,e   Lyons, Timothy J ^e   Baker, Nathaniel L ^c   Gilbert, Gregory E ^c   Virella, Gabriel ^a,f   Lopes Virella, Maria F ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^f Medical University of South Carolina ^*  (United States)

Author keywords

Diabetes; Intima media thickness; LDL autoantibodies; Lipoprotein subclasses; Statistical mediation analysis

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MACROGOL;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CAROTID ARTERY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; ANTIGEN-ANTIBODY COMPLEX; BLOOD CHEMICAL ANALYSIS; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OSMOLAR CONCENTRATION; PARTICLE SIZE; SEX CHARACTERISTICS;

EID: 79952317716     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2010.03.001     Document Type: Article

References (30)

1. Baynes J.W. Glycoxidation and lipoxidation in atherogenesis FreeaaRadical Biology & Medicine 28 2000 1708 1716 (Pubitemid 30628657)
2. Baynes J.W., and Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm Diabetes 48 1999 1 9 (Pubitemid 29019345)
3. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group Intensive diabetes therapy and carotid intima-media thickness in Type 1 diabetes mellitus The New England Journal of Medicine 348 2003 2294 2303
4. Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort Diabetes Care 22 1999 99 111
5. Jenkins A.J., Best J.D., Klein R.L., and Lyons T.J. Lipoproteins, glycoxidation, and diabetic angiopathy Diabet Metab Res Rev 20 2004 349 368
6. Jenkins A.J., Lyons T.J., Zheng D., Otvos J.D., Lackland D., McGee D., Garvey W.T., Klein R.L. and The DCCT/EDIC Research Group Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort J Investig Opthamol Vis Sci 45 2004 910 918 (Pubitemid 38868391)
7. Jenkins A.J., Lyons T.J., Zheng D., Otvos J.D., Lackland D.T., McGee D., Garvey W.T., Klein R.L. and The DCCT/EDIC Research Group Serum lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications cohort: Associations with gender and glycemia Diabetes Care 26 2003 810 818 (Pubitemid 36929348)
8. Jenkins A.J., Lyons T.J., Zheng D., Otvos J.D., Lackland D.T., McGee D., Garvey W.T., Klein R.L. and The DCCT/EDIC Research Group Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathy Kidney International 64 2003 817 828 (Pubitemid 37013817)
9. Jenkins A.J., Rowley K.G., Lyons T.J., Best J.D., Hill M.J., and Klein R.L. Lipoproteins and diabetic microvascular complications Current Pharmaceutical Design 10 2004 3395 3418 (Pubitemid 39276625)
10. Klein R.L., McHenry M.B., Lok K.H., Hunter S.J., Le N.A., Jenkins A.J., Zheng D., Semler A.J., Brown W.V., Lyons T.J., Garvey W.T. and The DCCT/EDIC Research Group Apolipoprotein C-III protein concentration and gene polymorphisms in type 1 diabetes: Associations with lipoprotein subclasses Metabolism 53 2004 1295 1303
11. Kramer C.Y. Extension of multiple range tests to group means with unequal numbers of replications Biometrics 12 1956 307 310
12. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., Ten S., Sanz M., Exley M., Wilson B., Porcelli S., and Maclaren M. Multiple immuno-regulatory defects in type-1 diabetes The Journal of Clinical Investigation 109 2002 131 140 (Pubitemid 34052549)
13. Lockwood C.M., and MacKinnon D.P. Bootstrapping the standard error of the mediated effect Paper presented at the 23rd Annual Meeting of SAS Users Group International, Cary, NC 1998
14. Lopes-Virella M.F., Binzafar N., Rackley S., Takei A., La Via M., and Virella G. The uptake of LDL-IC by human macrophages: Predominant involvement of the Fcγ-RI receptor Atherosclerosis 135 1997 161 170 (Pubitemid 28015182)
15. Lopes-Virella M.F., Klein R.L., and Virella G. Modification of lipoproteins in diabetes Diabet Metab Res Rev 12 1996 69 90 (Pubitemid 26164840)
16. Lopes-Virella M.F., McHenry M.B., Lipsitz S., Yim E., Wilson P.F., Lackland D.T., Lyons T.J., Jenkins A.J., Virella G. and The DCCT/EDIC Research Group Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes Atherosclerosis 190 2007 359 369 (Pubitemid 46074026)
17. Lopes-Virella M.F., and Virella G. The role of immune and inflammatory processes in the development of macrovascular disease in diabetes Frontiers in Bioscience. 8 2003 s750 768
18. Lopes-Virella M.F., Virella G., Orchard T.J., Koskinen S., Evans R.W., Becker D.J., and Forrest K.Y. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus Clinical Immunology 90 1999 165 172 (Pubitemid 29162161)
19. Lyons T.J., Jenkins A.J., Zheng D., Klein R.L., Otvos J.D., Yu Y., Lackland D.T., McGee D., McHenry M.B., Lopes-Virella M.F., Garvey W.T. and The DCCT/EDIC Research Group Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness Diabetic Medicine 23 2006 955 966 (Pubitemid 44257939)
20. MacKinnon D., Lockwood C.M., Hoffman J.M., West S.G., and Sheets V. A comparison of methods to test mediation and other intervening variable effects Psychological Methods 7 2002 83 104
21. Mironova M., Virella G., Virella-Lowell I., and Lopes-Virella M.F. Anti-modified LDL antibodies and LDL-containing immune complexes in IDDM patients and healthy controls Clinical Immunology and Immunopathology 85 1997 73 82 (Pubitemid 27432005)
22. Mora S., Szklo M., Otvos J.D., Greenland P., Psaty B.M., Goff D.C. Jr., O'Leary D.H., Saad M.F., Tsai M.Y., and Sharrett A.R. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA) Atherosclerosis 192 2007 211 217 (Pubitemid 46602300)
23. Orchard T.J., Forrest K.Y.Z., Becker D.J., Virella G., and Lopes-Virella M.F. Antibodies to oxidized LDL predict CAD in Type I diabetes: A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications Study Diabetes 48 1999 1454 1458 (Pubitemid 29297310)
24. Otvos J.D. Measurement of lipoprotein subclass particles by NMR spectroscopy Clinical Laboratory 48 2002 171 180 (Pubitemid 34272531)
25. Saad A.F., Virella G., Chassereau C.N., Boackle R.J., and Lopes-Virella M.F. Autoimmune OxLDL immune-complexes activate the classical pathway of complement and induce cytokine production by Mono Mac 6 cells and primary human macrophages Journal of Lipid Research 47 2006 1975 1983 (Pubitemid 44401985)
26. Tukey, J.W. (1953). The problem of multiple comparisons. Unpublished report, Princeton University, Princeton, NJ.
27. Virella G., Atchley D.H., Koskinen S., Zheng D., and Lopes-Virella M.F. Proatherogenic and pro-inflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL Clinical Immunology 105 2002 81 92 (Pubitemid 35222245)
28. Virella G., Derrick M.B., Pate V., Chassereau C., Thorpe S.R., and Lopes-Virella M.F. Development of capture assays for different modifications of human low-density lipoprotein Clinical and Diagnostic Laboratory Immunology 12 2005 68 75
29. Yla-Herttuala S., Palinski W., Butler S.W., Picard S., Steinberg D., and Witztum J.L. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL Atheroscler Thromb 14 1994 32 40
30. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., and Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man The Journal of Clinical Investigation 84 1989 1086 1095 (Pubitemid 19247577)